Need of booster vaccine doses to counteract the emergence of SARS-CoV-2 variants in the context of the Omicron variant and increasing COVID-19 cases: An update

The emergence of different variants of SARS-CoV-2, including the Omicron (B.1.1.529) variant in November 2021, has resulted in a continuous major health concern at a global scale. Presently, the Omicron variant has spread very rapidly worldwide within a short time period. As the most mutated variant...

Full description

Bibliographic Details

Published in:	Human Vaccines & Immunotherapeutics
Main Authors:	Ranjan K. Mohapatra, Nahed A. El-Shall, Ruchi Tiwari, Firzan Nainu, Venkataramana Kandi, Ashish K. Sarangi, Teroj Abdulrahman Mohammed, Perumal Arumugam Desingu, Chiranjib Chakraborty, Kuldeep Dhama
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2022-11-01
Subjects:	sars-cov-2 omicron variant b.1.1.529 vaccines booster doses enhancing immunity protection
Online Access:	http://dx.doi.org/10.1080/21645515.2022.2065824